uniQure Researchers Swap Out Lead Drug for a Better Prospect Post author:Sam Post published:October 18, 2017 Post category:BioPharma The company plans to expeditiously advance AMT-061 instead of AMT-060. Source: BioSpace You Might Also Like Ocular Therapeutix to Slash Jobs After FDA Rejection August 1, 2017 BASi Names Senior Vice President Of Preclinical Services March 8, 2017 Tiny Bicycle Therapeutics Wrangles a $424 Million R&D Pact With Biogen Spinoff Bioverativ September 5, 2017
Tiny Bicycle Therapeutics Wrangles a $424 Million R&D Pact With Biogen Spinoff Bioverativ September 5, 2017
